Skip to content

Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study

Immediate Versus Delayed Stenting in Patients With ST-Elevation Myocardial Infarction Undergoing Mechanical Intervention

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01462188
Acronym
OPTIMASTRATEGY
Enrollment
100
Registered
2011-10-31
Start date
2011-10-31
Completion date
2015-10-31
Last updated
2011-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

ST-segment elevation myocardial infarction, Primary angioplasty, stent

Brief summary

The goal of primary PCI is to restore anterograde myocardial flow. Stenting a largely thrombotic lesion may determine distal embolisation of thrombotic material therefore deteriorating myocardial perfusion.

Detailed description

In the setting of largely thrombotic lesions such as those treated in the context of primary PCI, stenting often results in distal micro and macro-embolisation which hampers coronary flow and microvascular recovery. Interestingly in some of these studies comparing BMS versus balloon angioplasty an early hazard associated to the use of stent has been reported. Thus, investigators hypothesize in this protocol that refraining from stenting during the acute phase of ST segment myocardial infarction is safe and associated to improved myocardial recovery as compared to acute stenting.

Interventions

Primary coronary stenting

PROCEDUREDelayed stenting

Coronary stenting 3 to 7 days after having reopened the vessel in the acute phase

Sponsors

Marco Valgimigli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chest pain for \>30 min with ST-segment elevation of one mm or more in 2 or more contiguous ECG leads or with presumably new left bundle-branch block * admission either within 12 h of symptom onset or between 12 and 24 h with evidence of continuing ischaemia

Exclusion criteria

* the

Design outcomes

Primary

MeasureTime frameDescription
Myocardial blush grade (MBG) equal or greater than 2post-procedureThe MBG will be estimated visually by 2 experienced observers, as previously described.

Secondary

MeasureTime frameDescription
ST segment elevation Resolution90 minutes after the procedure
infarct size5 daysInfarct size will be quantified by MRI
ST segment elevation resolution30 minutes after the procedureCumulative ST segment elevation in all leads will be quantified before and after the procedure and expressed as percentage
microvascular obstruction5 daysmicrovascular obstruction will be quantified by MRI
Mortality6 monthsoverall and cardiac mortality will be assessed up to 6 months
Infarct size6 monthsInfarct size will be quantified by MRI

Countries

Italy

Contacts

Primary ContactAlessandro Dal Monte, MD
dalmo_it@yahoo.it3487243479
Backup ContactMarco Valgimigli, MD, PhD
vlgmrc@unife.it3356478877

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026